|
Analysis of Mycotoxins in Dust Samples From a Water Damaged Building
|
Research Initiative
|
CDC
|
NIEHS
|
These studies are developing methods to quantitate the levels of fungal products in dust samples from water damaged buildings so that biomarkers of effect, such as fungal specific antibodies, can be correlated with biomarkers of exposure.
|
|
Anti-Infective Drugs Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.
|
|
Antimicrobial Resistance Challenge Working Group
|
Meeting/ Workshop
|
CDC, FDA, OSG
|
OD/DPCPSI, NIAID, OD/OIR/OTT, OD/OLPA, OD/OSP
|
Description of Collaborative Activity: On September 18, 2014, the President issued Executive Order 13676 on Combating Antibiotic-Resistant Bacteria and the and the Antimicrobial Resistance Challenge was called for in the accompanying White House Fact Sheet. The development and use of rapid, point-of-care, and innovative diagnostic tests for identification and characterization of resistant bacteria was a goal identified in the National Strategy for Combating Antibiotic-Resistant Bacteria released in September 2014 and addressed in the National Action Plan for combating Antibiotic-Resistant Bacteria released in March 2015. In conformance with the previous documents, the NIH and BARDA are sponsoring a prize competition, and the FDA and CDC are contributing technical and regulatory expertise to develop the award evaluation process. The aim of the prize competition is to incentivize the development of one or more in vitro diagnostic tests that would be of significant clinical and public health utility to combat the development and spread of antibiotic resistant bacteria. The AMR Challenge Working Group meets bi-weekly.
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC, FDA, HRSA
|
NICHD
|
This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by various pharmaceutical companies and has a committee of external experts and government staff from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). The registry provides a resource for clinicians and researchers to improve the healthcare quality and patient safety for HIV infected mothers and their infants.
|
|
Asbestos Workshop
|
Meeting/ Workshop
|
CDC
|
NIEHS
|
This meeting will include discussion of nomenclature and characterization of asbestos-like materials, giving us the perfect opportunity to establish an interdisciplinary discussion regarding the characteristics of mineral fibers that cause disease. The overall combined conference is planned to take place on September, 2016, at Lister Hill Auditorium in Washington, DC. The working title for the 1.5-day NIOSH workshop is, “Elongate Mineral Fiber Terminology and Characterization”.
|
|
Asia-Pacific Economic Cooperation (APEC) Cervical Cancer Initiative
|
Meeting/ Workshop
|
OS
|
NCI
|
NCI/CGH and HHS/OS/OGA have been supporting a collaborative effort to strengthen cervical cancer control through the Asia-Pacific Economic Forum (APEC). Effective cervical cancer control strategies exist all along the cervical cancer control continuum, including primary prevention, screening, treatment, and palliative care. Recent research has demonstrated the effectiveness of lower cost screening techniques, and ongoing research is exploring additional reduced-cost cervical cancer control options. The large number of interventions currently available and on the horizon means that the integration of these approaches into health systems is possible for economies of many different resource levels and can have substantial impact on public health, the workforce, and the broader economy.
|
|
Assay Guidance Manual (AGM) Workshop
|
Meeting/ Workshop
|
FDA
|
NCATS, NCI, NEI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMH, NINR
|
NCATS Assay Guidance Manual, an eBook developed in coordination with an international editorial board and colleagues at Eli Lilly and Company, is a 32-chapter how-to guide for researchers on developing and using assays in high-throughput screening projects. In February 2015, the manual’s editors held an inaugural workshop, "Assay Guidance for High Throughput Screening and Lead Discovery," at the NCATS laboratories in Rockville, Maryland. The goal of the workshop, which was aimed at scientists who are new to the drug discovery community, was to provide a broad introduction and baseline information for developing assay methods. Participants included intramural researchers from many NIH Institutes and Centers and the Food and Drug Administration. Activities included presentations about critical fundamental concepts relevant to researchers with diverse backgrounds and interests, demonstrations and tours, and small group discussions.
|
|
Assay Guidance Workshop For High Throughput Screening And Lead Discovery
|
Meeting/ Workshop
|
FDA
|
NCATS, CC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMH, NIMHD, NINDS
|
Researchers from NCATS and the Food and Drug Administration (FDA) hosted the, "Assay Guidance Workshop for High-Throughput Screening and Lead Discovery", in July 2015 at the Harvey W. Wiley Federal Building in College Park, Maryland. The goal of the workshop was to share best practices and advice for robust assay design and development with scientists who are new to the drug discovery community. More than two hundred participants attended the event, including intramural researchers from many NIH Institutes and Centers, the FDA, the National Institute of Standards and Technology, and the Environmental Protection Agency. The workshop included seven lectures by leading drug discovery scientists and editors of the Assay Guidance Manual. A similar workshop will be held at the 2016 annual conference of the Society for Laboratory Automation and Screening in San Diego in January.
|
|
Assessment of Occupational Exposure to Coal Tar Pitch Volatiles Containing Polycyclic Aromatic Hydrocarbons (PAHs) in Coal Tar Sealant Applications
|
Research Initiative
|
CDC
|
NIEHS
|
This study will measure exposure of coal tar sealant applicators to polycyclic aromatic hydrocarbons (PAHs) compounds.
|
|
Assessment of Occupational Exposure to Flame Retardants
|
Research Initiative
|
CDC
|
NIEHS
|
To characterize occupational exposure to flame retardants among U.S. workers who are manufacturing or installing flame retardant materials.
|